ARCHIVES

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Congress Approves More Favorable Terms for Office-Administered Drugs

August 8, 1997

Senate Authorizes $30 Million For Childhood Cancer Clinical Trials Research.

July 18, 2008

Rewritten Five Year Plan For Centers Is Greeted Warmly By NCAB Committee

April 27, 1990

Six NY Institutes Form Cancer Vaccine Collaboration

November 8, 2002

PFS Is A Benefit “In The Right Context,” Pazdur Says In Q&A On Avastin Approval.

February 29, 2008

Senate Vote On Override Of NIH Reauthorization Veto Delayed Until After US-USSR Summit Meeting

November 22, 1985